A new enzymatic method for the determination of inulin in plasma and urine, using inulase (EC 3.2.1.7), fructokinase (EC 2.7.1.4), phosphoglucoisomerase (EC 5.3.1.9) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) is described. The assay is based on the hydrolysis of inulin or Inutest (Inutest" which is the injectable form of inulin), by inulase and the determination of fructose released.
Inulin clearance is regarded as the most accurate method of measuring glomerular filtration rate (GFR). In the current methods for the determination on inulin, based on the reduction and formation of colour with diphenylamine or anthrone, endogenous glucose interferes and this must be removed.':" The determination of inulin using inulase (EC 3.2.1.7) and hexokinase also requires the removal of endogenous glucose. S To overcome this problem, we have developed an enzymatic assay which does not require prior removal of glucose.
For this method inulase, fructokinase (FK; EC 2.7.1.4), phosphoglucoisomerase (PGI; EC 5.3.1.9), and glucose-S-phosphate dehydrogenase (G6PDH; EC 1.1.1.49) are used. The method is based on the determination of fructose produced by hydrolysis of inulin by inulase. The principle of the method can be summarized as follows: We have used Inutest, the injectable form of inulin throughout this study.
MATERIALS AND METHODS

Materials
Inulase and FK were obtained from International Reagents (Kobe, Japan), PGI from Boehringer Mannheim (Yamanouchi, Tokyo, Japan); ATP was obtained from Oriental Yeast Industries (Tokyo, Japan). Inutest (Inutest" 5 g120 mL, molecular weight; 2000-4500) was obtained from Laevosan GmbH (Linz, Austria). Inulin (molecular weight; approximately 5000) was obtained from Wako Pure Chemicals (Osaka, Japan). 
Comparison of the enzymatic and anthrone methods
To assess the validity of our enzymatic technique, comparative studies were undertaken using the anthrone method described by White and Samson.' Briefly, plasma samples were deproteinized by adding at least 10 Vol of 0·3 mollL trichloroacetic acid and centrifuging at 3000 rpm for 10 min. Aliquot of the deproteinized sample (200 ILL) was mixed with 4· 0 mL anthrone reagent (100 mmollL anthrone in 700 milL sulphuric acid) and incubated in a 56°C water bath for 10 min. After cooling (1 min in an ice bath, then 24 min at room temperature), the absorbance at 636 nm was read.
Plasma samples were obtained from patients suffering from kidney disease (n = 60) and from diabetic nephropathy (n = 4). The mean age was 44' 5 (range 14-72) years. The range of plasma urea and creatinine concentrations in the samples were 2·9 to 26· 1 mmol/L and 26·5 to 406·6 ILmollL, respectively. We added Inutest at several concentrations to these plasma samples and used them to compare the enzymatic and anthrone methods.
Comparison of GFR measured by the enzymatic and thiosulphate methods
We compared GFR determined by the enzymatic method with that determined using thiosulphate, which is the most widely used method for measuring GFR in Japan, in 37 subjects. The mean age of the subjects was 46· 1 (range 17-72) years and the range of plasma urea and creatinine concentrations were 2·9 to 26· 1 mmollL and 26' 5 to 406·6 fLmollL, respectively. In patients with normal GFR a solution containing 1· 7% Inutest and 3·3% thiosulphate was infused microlitres of reagent-2 were then added, and the mixture incubated at 37°C for 21 min, and the rate of increase in absorbance at 340 nm was recorded. The concentration in the sample was determined using a 1 giL standard solution of Inutest.
Interference studies
To determine the effects of various additives 27· 7 mmollL glucose, 1· 7 mmollL fructose or 1 ·7 mmollL mannose were added to plasma containing 209 mg/L of Inutest, and to urine containing 406 mg/L of Inutest and analysed. Triglycerides, haemoglobin, bilirubin, urea and creatinine were added to plasma and urine containing Inutest and analysed. 
Reagents
Two enzyme solutions were prepared for the assay. Reagent-I, consisting of I'5mmollL of i3-NADP, 7 U/mL of G6PDH and 13 mmollmL of ATP-2Na, 20 U/mL of PGI, 6 U/mL of FK and 13 mmollL of MgCI 2 , was prepared in 100 mmollL HEPES buffer (pH 7· 5). Reagent-2 contained inulase in the same buffer at a final concentration of 80 U/mL. Standard solutions of Inutest were prepared from Inutest ampules by diluting it with distilled water containing O· 10(0 sodium azide.
Procedure
The procedure was adapted for a Cobas" FARA (Japan Roche, Tokyo, Japan), with the settings in Table 1 . Urine samples were diluted IO times with distilled water before analysis. Samples or standards were mixed on the analyser with 280 ILL of reagent-l and incubated at 37°C for 5 min, at which time the absorbance at 340 nm was recorded. During this incubation endogenous fructose in the samples was degraded. Seventy Within-run precision carried out by assaying 10 replicates each of three pooled plasma samples was 1· 66010, 2· 32% and 1.07% at mean Inutest values of 131·2, 254· 4 and 986· 0 mglL, respectively. Between-run precision over a period of 9 days using pooled plasma was 2·15% at a mean value of 258· 5 mg/L. at a rate of 4 mllmin for the first 5 min, then, at a rate of 2 mllmin, until the end of the examination. The concentrations of Inutest and 2000 thiosulphate administered to patients with reduced GFR were determined from their body surface area and the degree of renal impairment. Blood and urine samples were colIected before infusion and at 20 and 40 min after the start of infusion. Thiosulphate in urine and plasma were determined by the method of Brun." GFR was calculated and adjusted for a surface area of 1·48 m 2 which is Japanese standard for body surface area.
Linearity test and precision studies (Fig. 1) The assay was linear up to 2 giL when assessed by diluting plasma and urine with distilled water.
Properties of inulase and FK
The properties of the inulase and FK are as shown in Table 2 . FK which was purified from Pseudomonas sp. KN-21 strain by the method of Murao et at,' was specific for fructose. The Michaelis constant (Km) of inulase for inulin was calculated assuming the molecular weight of inulin to be approximately 5000. The Km of inulase for Inutest could not be calculated as the molecular weight of Inutest could only be estimated to be between 2000-4500. 
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Recovery studies The mean recovery of Inutest added to pooled plasma was 99·4% and it was 100·5% in urine ( Table 3) .
Interference studies Glucose (27' 7 mmol/L), fructose (I' 7 mmol/L) and mannose (I. 7 mmol/L) when added to plasma or urine produced no interference. No significant interference was also detected with triglycerides (3' 0 giL), haemoglobin (5 giL), bilirubin (342 JLmol/L), urea (35' 7 mmol/L) or creatinine (884 JLmol/L).
Comparison of the enzymatic and anthrone methods
When the enzymatic and anthrone methods were compared, the plasma Inutest concentrations tended to be somewhat higher by the enzymatic method ( Fig. 2) especiallyat higher concentrations. The regression equation was y = I . I763x -93· 35, where x is the anthrone method and y is the enzymatic method and the correlation coefficient was 0'979.
Comparison of GFR by the enzymatic and thiosulphate methods
The GFR values determined by the enzymatic method correlated with that arrived by the thiosulphate method (r = 0'979, y = O' 8902x -O'92, where x is the thiosulphate method, and y is the enzymatic method). As shown in Fig. 3 when the GFR was normal the enzymatic method gave lower results.
DISCUSSION
The advantages of the present enzymatic method are twofold: first, that it is specific for inulin (lnutest); and, second, that it is unaffected by glucose normally present in plasma and urine. The addition of 27· 7 mmol/L glucose had no noticeable effect on the results. This corresponds A comparison of Inutest concentration measured by the enzymatic method, with that measured by the anthrone method. We added varying concentrations of Inutest to plasma from patients with renal disease (e) and diabetic nephropathy (0). subjects. The addition of 1·7 mmollL fructose did not affect Inutest values. An enzymatic method using inulase and sorbitol dehydrogenase (SDH; Ee 1.1.1.14) has been described by several researchers.v '! However, this method is also subject to interference from glucose; in the presence of 1·7 mmollL glucose inulin concentration was 1·3 mg/L higher .'"
We conclude that this enzymatic assay using inulase and FK is specific for inulin and can be used to determine GFR in clinical practice.
